Drug developer Pharmaxis to slash 45 jobs
Drug developer Pharmaxis will slash 45 jobs and cut costs as the company undertakes a major restructure after encountering regulatory problems.
Pharma major Merck & Co on Wednesday said it will slash 7,200 jobs, which account for more than 12 per cent of the drug maker's global workforce, as part of restructuring efforts.